Assessing the Impact of Screening Colonoscopy on Mortality in the Medicare Population
- 13 August 2011
- journal article
- research article
- Published by Springer Nature in Journal of General Internal Medicine
- Vol. 26 (12) , 1441-1449
- https://doi.org/10.1007/s11606-011-1816-4
Abstract
Some have recommended against routine screening for colorectal cancer (CRC) among patients ≥75 years of age, while others have suggested that screening colonoscopy (SC) is less beneficial for women than men. We estimated the expected benefits (decreased mortality from CRC) and harms (SC-related mortality) of SC based on sex, age, and comorbidity.Keywords
This publication has 52 references indexed in Scilit:
- Low Risk of Colorectal Cancer and Advanced Adenomas More Than 10 Years After Negative ColonoscopyGastroenterology, 2010
- Differences in Colon Adenomas and Carcinomas Among Women and MenJAMA, 2009
- The Payoff TimeMedical Care, 2009
- Colorectal Cancer Screening by Primary Care PhysiciansAmerican Journal of Preventive Medicine, 2009
- Colonoscopy in Colorectal-Cancer Screening for Detection of Advanced NeoplasiaNew England Journal of Medicine, 2006
- Criterion Validity of Medicare Chemotherapy Claims in Cancer and Leukemia Group B Breast and Lung Cancer Trial ParticipantsJNCI Journal of the National Cancer Institute, 2005
- Construct Validity of Medicare Chemotherapy ClaimsMedical Care, 2002
- Randomised study of screening for colorectal cancer with faecal-occult-blood testThe Lancet, 1996
- Randomised controlled trial of faecal-occult-blood screening for colorectal cancerThe Lancet, 1996
- Protection by endoscopy against death from colorectal cancer. A case-control study among veteransArchives of internal medicine (1960), 1995